Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
280
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Disease, End-Stage
End-stage Renal Disease
Arteriovenous Fistula
Interventions
DEVICE:
EndoAVF Creation
Sponsor
C. R. Bard